Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Acorda Therapeutics, Inc.

Acorda Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Therapeutics Enters into License Agreement with Asieris Pharmaceuticals
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Therapeutics Announces Resignation of Chief Operating Officer
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Therapeutics Reports Second Quarter 2022 Financial Results
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Second Quarter 2022 Update: Webcast/Conference Call Scheduled for August 4, 2022
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Esteve Launches INBRIJA® in Germany
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Therapeutics Reports First Quarter 2022 Financial Results
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Therapeutics and Biopas Laboratories Announce Agreement to Commercialize INBRIJA® in Latin America
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda First Quarter 2022 Update: Webcast/Conference Call Scheduled for May 11, 2022
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Fourth Quarter/Year End 2021 Update: Webcast/Conference Call Scheduled for March 9, 2022
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
John Varian Joins Acorda Therapeutics Board of Directors
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Germany
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Therapeutics Reports Third Quarter 2021 Financial Results, Additions to Leadership Team
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Therapeutics Announces Corporate Restructuring, Management Changes
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Therapeutics Reports Second Quarter 2021 Financial Results
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Second Quarter 2021 Update: Webcast/Conference Call Scheduled for August 5, 2021
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Spain
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Therapeutics Announces Repayment of Convertible Senior Notes
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Therapeutics Reports First Quarter 2021 Financial Results
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Acorda Therapeutics First Quarter 2021 Update: Webcast/Conference Call Scheduled for May 6, 2021
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Celebrity Chef Zarela Martinez Partners with Acorda Therapeutics on the launch of “A Taste for Life with Zarela℠”
From Acorda Therapeutics, Inc.
Via Business Wire
Tickers ACOR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.